CKD Biomarkers Consortium Pilot & Feasibility Program
The CKD Biomarkers Consortium Pilot and Feasibility Program is focused on the discovery, validation, or qualification of CKD biomarkers in adults and children. The CKD BioCon Scientific and Data Coordinating Center (SDCC) at The University of Pennsylvania administers this program. Successful pilot and feasibility studies serve as a basis for subsequent applications for independent research support. Typical awardees have either been early stage investigators or investigators who are pursuing new research directions related to CKD biomarkers.
The program accepts applications from two focused areas:
- Applications proposing studies of biomarkers that are measured in human blood, urine, or renal tissue, or extracted from radiographic/imaging data and that seek to address important research questions related to the occurrence, progression, and/or consequences of CKD.
- Applications proposing the development and/or evaluation of new statistical methods relevant to biomarkers which are specifically related to CKD biomarkers.
The CKD BioCon is now ACCEPTING APPLICATIONS for FUNDING
Please note new higher level of budgeting permitted.
The application deadline for submissions has been EXTENDED to March 30, 2018.
- Link to Funding Announcement and Instructions on How to Apply
- Link to Funded Applications from Previous Cycles
For questions related to this program, please contact:
CKD Biomarkers Consortium Scientific and Data Coordinating Center
The Perelman School of Medicine at The University of Pennsylvania